Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v15-EN | Version v1-EN | |
---|---|---|
Language | English | English |
Date Updated | 2021-02-02 | 2020-09-28 |
Drug Identification Number | 02375532 | 02375532 |
Brand name | SANDOZ MEMANTINE FCT | SANDOZ MEMANTINE FCT |
Common or Proper name | SANDOZ MEMANTINE FCT | SANDOZ MEMANTINE FCT |
Company Name | SANDOZ CANADA INCORPORATED | SANDOZ CANADA INCORPORATED |
Ingredients | MEMANTINE HYDROCHLORIDE | MEMANTINE HYDROCHLORIDE |
Strength(s) | 10MG | 10MG |
Dosage form(s) | TABLET | TABLET |
Route of administration | ORAL ORAL | ORAL ORAL |
Packaging size | 100 FCT BO V1 CA | 100 FCT BO V1 CA |
ATC code | N06DX | N06DX |
ATC description | ANTI-DEMENTIA DRUGS | ANTI-DEMENTIA DRUGS |
Reason for shortage | Shortage of an active ingredient. | Shortage of an active ingredient. |
Anticipated start date | ||
Actual start date | 2020-09-25 | 2020-09-25 |
Estimated end date | 2021-01-29 | 2020-10-30 |
Actual end date | 2021-02-01 | |
Shortage status | Resolved | Actual shortage |
Tier 3 Status | No | No |
Company comments | ||
Health Canada comments |